Loading…

Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker

Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2004-03, Vol.10 (6), p.1984-1991
Main Authors: CHANG QI ZHU, BLACKHALL, Fiona H, TSAO, Ming-Sound, PINTILIE, Melania, IYENGAR, Pratibha, NI LIU, HO, James, CHOMIAK, Taylor, LAU, Davina, WINTON, Timothy, SHEPHERD, Frances A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593
cites cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593
container_end_page 1991
container_issue 6
container_start_page 1984
container_title Clinical cancer research
container_volume 10
creator CHANG QI ZHU
BLACKHALL, Fiona H
TSAO, Ming-Sound
PINTILIE, Melania
IYENGAR, Pratibha
NI LIU
HO, James
CHOMIAK, Taylor
LAU, Davina
WINTON, Timothy
SHEPHERD, Frances A
description Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC). Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level and ras mutation. These values were correlated with the clinical and pathological features of the patients. Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker. Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.
doi_str_mv 10.1158/1078-0432.CCR-03-0470
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71756874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71756874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</originalsourceid><addsrcrecordid>eNpNkd1u1DAQhSMEoj_wCKC5AfWCFDuOY-dyFUFZafsjWq6tWcfZNd3YqZ1Q-jC8Kw67CG7GI_k7M_Y5WfaGknNKufxIiZA5KVlx3jRfc8JSL8iz7JhyLnJWVPx56v8yR9lJjN8JoSUl5cvsiHJSUkGr4-zX7f1QwIVxBho_PMHV1K9NgEUqAUfrXYRFmO_63juwDq68y2973O2gMamsJreBBoO2zvf4AdC1sBwjXP8wwfwcgonR7oV3U-9DhEc7biFghMtp_LMAlhEQbrwPcBP8xvk4Wg2XGO5NeJW96HAXzevDeZp9-_zprvmSr64vls1ilWsmyJhTXDNTMElYgVUtOatrrWXXSa275EpZU2wlQ226Fg2p1m1dcVEwiozqlvKanWbv93OH4B8mE0fV26jT_9AZP0UlqOCVFGUC-R7UwccYTKeGYHsMT4oSNeeiZs_V7LlKuSjC1JxL0r09LJjWvWn_qQ5BJODdAcCocdcFdNrG_zguqZDzoLM9t7Wb7aMNRulEprBMNCmF7fyOStFaluw3cROkyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71756874</pqid></control><display><type>article</type><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><source>Freely Accessible Journals</source><creator>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</creator><creatorcontrib>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</creatorcontrib><description>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC). Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level and ras mutation. These values were correlated with the clinical and pathological features of the patients. Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker. Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-03-0470</identifier><identifier>PMID: 15041716</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic agents ; Base Sequence ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - pathology ; Cell Line, Tumor ; Chromosome Aberrations ; DNA Primers ; Female ; Gene Expression Regulation, Neoplastic - genetics ; Genes, ras - genetics ; Humans ; Lung Neoplasms - genetics ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Mutation ; Neoplasm Staging ; Pharmacology. Drug treatments ; Polymerase Chain Reaction - methods ; Prognosis ; S-Phase Kinase-Associated Proteins - genetics ; Survival Analysis ; Tumors</subject><ispartof>Clinical cancer research, 2004-03, Vol.10 (6), p.1984-1991</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</citedby><cites>FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15581780$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15041716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHANG QI ZHU</creatorcontrib><creatorcontrib>BLACKHALL, Fiona H</creatorcontrib><creatorcontrib>TSAO, Ming-Sound</creatorcontrib><creatorcontrib>PINTILIE, Melania</creatorcontrib><creatorcontrib>IYENGAR, Pratibha</creatorcontrib><creatorcontrib>NI LIU</creatorcontrib><creatorcontrib>HO, James</creatorcontrib><creatorcontrib>CHOMIAK, Taylor</creatorcontrib><creatorcontrib>LAU, Davina</creatorcontrib><creatorcontrib>WINTON, Timothy</creatorcontrib><creatorcontrib>SHEPHERD, Frances A</creatorcontrib><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC). Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level and ras mutation. These values were correlated with the clinical and pathological features of the patients. Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker. Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic agents</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Cell Line, Tumor</subject><subject>Chromosome Aberrations</subject><subject>DNA Primers</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Genes, ras - genetics</subject><subject>Humans</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasm Staging</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Prognosis</subject><subject>S-Phase Kinase-Associated Proteins - genetics</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpNkd1u1DAQhSMEoj_wCKC5AfWCFDuOY-dyFUFZafsjWq6tWcfZNd3YqZ1Q-jC8Kw67CG7GI_k7M_Y5WfaGknNKufxIiZA5KVlx3jRfc8JSL8iz7JhyLnJWVPx56v8yR9lJjN8JoSUl5cvsiHJSUkGr4-zX7f1QwIVxBho_PMHV1K9NgEUqAUfrXYRFmO_63juwDq68y2973O2gMamsJreBBoO2zvf4AdC1sBwjXP8wwfwcgonR7oV3U-9DhEc7biFghMtp_LMAlhEQbrwPcBP8xvk4Wg2XGO5NeJW96HAXzevDeZp9-_zprvmSr64vls1ilWsmyJhTXDNTMElYgVUtOatrrWXXSa275EpZU2wlQ226Fg2p1m1dcVEwiozqlvKanWbv93OH4B8mE0fV26jT_9AZP0UlqOCVFGUC-R7UwccYTKeGYHsMT4oSNeeiZs_V7LlKuSjC1JxL0r09LJjWvWn_qQ5BJODdAcCocdcFdNrG_zguqZDzoLM9t7Wb7aMNRulEprBMNCmF7fyOStFaluw3cROkyQ</recordid><startdate>20040315</startdate><enddate>20040315</enddate><creator>CHANG QI ZHU</creator><creator>BLACKHALL, Fiona H</creator><creator>TSAO, Ming-Sound</creator><creator>PINTILIE, Melania</creator><creator>IYENGAR, Pratibha</creator><creator>NI LIU</creator><creator>HO, James</creator><creator>CHOMIAK, Taylor</creator><creator>LAU, Davina</creator><creator>WINTON, Timothy</creator><creator>SHEPHERD, Frances A</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040315</creationdate><title>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</title><author>CHANG QI ZHU ; BLACKHALL, Fiona H ; TSAO, Ming-Sound ; PINTILIE, Melania ; IYENGAR, Pratibha ; NI LIU ; HO, James ; CHOMIAK, Taylor ; LAU, Davina ; WINTON, Timothy ; SHEPHERD, Frances A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic agents</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Cell Line, Tumor</topic><topic>Chromosome Aberrations</topic><topic>DNA Primers</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Genes, ras - genetics</topic><topic>Humans</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasm Staging</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Prognosis</topic><topic>S-Phase Kinase-Associated Proteins - genetics</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHANG QI ZHU</creatorcontrib><creatorcontrib>BLACKHALL, Fiona H</creatorcontrib><creatorcontrib>TSAO, Ming-Sound</creatorcontrib><creatorcontrib>PINTILIE, Melania</creatorcontrib><creatorcontrib>IYENGAR, Pratibha</creatorcontrib><creatorcontrib>NI LIU</creatorcontrib><creatorcontrib>HO, James</creatorcontrib><creatorcontrib>CHOMIAK, Taylor</creatorcontrib><creatorcontrib>LAU, Davina</creatorcontrib><creatorcontrib>WINTON, Timothy</creatorcontrib><creatorcontrib>SHEPHERD, Frances A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHANG QI ZHU</au><au>BLACKHALL, Fiona H</au><au>TSAO, Ming-Sound</au><au>PINTILIE, Melania</au><au>IYENGAR, Pratibha</au><au>NI LIU</au><au>HO, James</au><au>CHOMIAK, Taylor</au><au>LAU, Davina</au><au>WINTON, Timothy</au><au>SHEPHERD, Frances A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2004-03-15</date><risdate>2004</risdate><volume>10</volume><issue>6</issue><spage>1984</spage><epage>1991</epage><pages>1984-1991</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Purpose: Skp2 plays a critical role in cell cycle progression, especially at the G 1 -S transition, putatively through its control of several cell cycle regulator proteins. The Skp2 gene is located on a region of chromosome 5p that is commonly overrepresented in lung cancer. The present study aimed to evaluate Skp2 abnormalities and their prognostic value in non-small cell lung cancer (NSCLC). Experimental Design: In total 16 NSCLC cell lines and 163 primary tumors were included in studies to measure Skp2 relative gene copy number, mRNA abundance, and protein level. The tumors were also evaluated for p27 protein expression level and ras mutation. These values were correlated with the clinical and pathological features of the patients. Results: Skp2 relative gene copy number aberrations were found in 88 and 65% of NSCLC cell lines and primary tumors, respectively. Overrepresentation was especially common among squamous cell carcinoma (74%). Both gene copy overrepresentation (13%) and loss (35%) were found in adenocarcinoma. Skp2 relative gene copy number was significantly correlated with mRNA and protein levels, but none of these were correlated with p27 protein levels. Neither high Skp2 protein expression nor ras mutation was prognostically significant. In NSCLCs with ras mutation, however, high Skp2 protein expression was a significant independent poor prognostic marker. Conclusion: There appears to be a synergistic interaction between high Skp2 protein expression and ras mutation with negative impact on the survival of NSCLC patients.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15041716</pmid><doi>10.1158/1078-0432.CCR-03-0470</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2004-03, Vol.10 (6), p.1984-1991
issn 1078-0432
1557-3265
language eng
recordid cdi_proquest_miscellaneous_71756874
source Freely Accessible Journals
subjects Adult
Aged
Aged, 80 and over
Antineoplastic agents
Base Sequence
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - mortality
Carcinoma, Non-Small-Cell Lung - pathology
Cell Line, Tumor
Chromosome Aberrations
DNA Primers
Female
Gene Expression Regulation, Neoplastic - genetics
Genes, ras - genetics
Humans
Lung Neoplasms - genetics
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Male
Medical sciences
Middle Aged
Mutation
Neoplasm Staging
Pharmacology. Drug treatments
Polymerase Chain Reaction - methods
Prognosis
S-Phase Kinase-Associated Proteins - genetics
Survival Analysis
Tumors
title Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skp2%20Gene%20Copy%20Number%20Aberrations%20Are%20Common%20in%20Non-Small%20Cell%20Lung%20Carcinoma,%20and%20Its%20Overexpression%20in%20Tumors%20with%20ras%20Mutation%20Is%20a%20Poor%20Prognostic%20Marker&rft.jtitle=Clinical%20cancer%20research&rft.au=CHANG%20QI%20ZHU&rft.date=2004-03-15&rft.volume=10&rft.issue=6&rft.spage=1984&rft.epage=1991&rft.pages=1984-1991&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-03-0470&rft_dat=%3Cproquest_cross%3E71756874%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-1ab3e238032a6985399cc8ff8ccf470491ad83acefdae06bd9657231a31cd1593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71756874&rft_id=info:pmid/15041716&rfr_iscdi=true